
Validea's guru fundamental report indicates that UNITEDHEALTH GROUP INC (UNH) receives a 69% rating based on the Martin Zweig Growth Investor model, which favors growth stocks with accelerating earnings and sales, reasonable valuations, and low debt; the stock passes several key tests related to revenue and EPS growth, but fails criteria for earnings persistence and long-term EPS growth, resulting in less than strong interest from this particular strategy.
UnitedHealth Group Inc. (UNH) has received a 69% rating from Validea's Growth Investor model, based on Martin Zweig's strategy which prioritizes stocks with persistent, accelerating earnings and sales growth, reasonable valuations, and low debt. This rating is below the 80% threshold that typically indicates strategy interest. UNH successfully meets several criteria of this model, including its P/E ratio, the alignment of revenue growth with EPS growth, its sales growth rate, current quarter earnings performance, and a positive earnings growth rate for the current quarter where EPS growth also exceeded that of the prior three quarters and its historical growth rate. Furthermore, insider transaction signals are positive. However, the company falls short on crucial long-term and consistency metrics: it failed the tests for quarterly earnings compared to one year ago, the earnings growth rate over the past several quarters, overall earnings persistence, and long-term EPS growth. This mixed performance, underscored by a slightly negative ticker-specific sentiment score of -0.1, suggests that while UNH exhibits some positive current growth characteristics, the lack of sustained earnings improvement and a weaker outlook for long-term EPS growth prevent a stronger endorsement from this particular growth-oriented investment strategy.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mixed
Sentiment Score
-0.05
Ticker Sentiment